Tokio X'press | Tokio X'press - Part 1817

💊Sunovion Receives FDA Approval of Supplemental New Drug Application (sNDA) for Use of Latuda (lurasidone HCl) in the Treatment of Bipolar Depression in Pediatric Patients (10 to 17 Years of Age)

Wednesday March 7th, 2018By Tokio X'press FDA, Pharmaceutical ds-pharma

🏭AGC Enhances Biopharmaceutical Production Capacity at AGC Biologics

Wednesday March 7th, 2018By Tokio X'press bio, Pharmaceutical AGC Biologics

📡Mitsubishi Electric to Launch Compact Integrated 400Gbps EML-TOSA Will support high-speed transmissions and large-capacity of optical fiber communication

Wednesday March 7th, 2018By Tokio X'press LSI, Communication mitsubishielectric

🍀Rakuten and TEPCO Group reach agreement on utilization of infrastructure for establishing MNO base stations

Wednesday March 7th, 2018By Tokio X'press smart phone, Communication Rakuten

🙇Report on the Kobe Steel Group’s misconduct

Wednesday March 7th, 2018By Tokio X'press Regulation, litigation KOBELCO